Foot Locker Inc. gained 0.5% to $18.35 after the footwear and apparel retailer reported weaker-than-expected sales in the fourth quarter of 2024.

Sales decreased to $2.24 billion from $2.38 billion, net income swung to a profit of $49 million from a loss of $389 million, and earnings per diluted share rose to a profit of 57 cents from a loss of $4.13 a year ago.

Sales in the 53rd week in 2023 were $98 million.

Overall comparable sales, including all banners and geographies, increased by 2.6%, and North America comparable same-store sales advanced 3.6%. 

Champs Sports delivered its second consecutive quarter of comparable sales growth, with gains of 1.8%.

Foot Locker completed 160 store refreshes in the fourth quarter, bringing the total to over 400 for the year.

The company guided for fiscal 2025 sales growth between -1% and 0.5%, comparable sales change between 1% and 2.5%, and non-GAAP earnings per share between $1.35 and $1.65, compared to $1.37 in 2024.

Abercrombie & Fitch Co. dropped 0.3% to $87.0 after the specialty apparel retailer reported comparable sales growth of 14% in the fiscal fourth quarter of 2024.

Net sales increased to $1.58 billion from $1.45 billion, net income climbed to $187.23 million from $158.45 million, and earnings per diluted share rose to $3.57 from $2.97 a year ago.

Full-year 2024 revenue increased 16% to $4.95 billion from $4.28 billion a year ago, driven by a 17% rise in comparable store sales.

The company guided for the first quarter of 2025 net sales growth between 4% and 6% and net income per diluted share between $1.25 and $1.45, compared to $2.14 in the same period in 2024.

For the full year, the apparel retailer estimated net sales growth between 3% and 5% and net income per diluted share between $10.40 and $11.40, compared to $10.69 in 2024.

Abercrombie & Fitch announced a new $1.3 billion share repurchase authorization, expecting $400 million in share repurchases during 2025.

Veeva Systems Inc. surged 7.2% to $235.69 after the provider of cloud solutions for the life sciences industry reported increased sales in the fiscal fourth quarter of 2025 ending in January.

Revenue jumped to $720.89 million from $630.62 million, net income increased to $195.62 million from $147.40 million, and earnings per diluted share rose to $1.18 from 90 cents a year ago.

The company guided for the first quarter of 2026 revenue between $726 million and $729 million, compared to $650.3 million, and non-GAAP earnings per diluted share between $1.74 and $1.75, compared to $1.50 in the previous year.

Non-GAAP operating income is expected to be between $307 million and $309 million, compared to $247.0 million in the first quarter of 2025.

For the full year, Veeva estimated revenue between $3.04 billion and $3.05 billion, up from $2.75 billion a year ago, and non-GAAP earnings per diluted share at approximately $7.32, compared to $6.60 in 2025.

Non-GAAP operating income is expected at $1.30 billion, compared to $1.15 billion in 2025.

MongoDB Inc. plunged 17.4% to $218.10 after the developer data platform provider missed fourth-quarter analysts expectations.

Fourth-quarter 2025 revenue increased to $548.40 million from $458.00 million, net income jumped to $15.83 million from a loss of $55.46 million, and earnings per diluted share rose to 19 cents from a loss of 77 cents a year ago.

The company guided for the first quarter of 2026 revenue between $524 million and $529 million, up from $450.6 million a year ago, and non-GAAP net income per share between 63 cents and 67 cents, compared to 51 cents in the same quarter in 2025.

Non-GAAP income from operations is expected to be between $54 million and $58 million, up from $32.8 million in the first quarter of 2025.

MongoDB announced a stock buyback program of $200 million to offset the impact of last year’s acquisition of Voyage AI, a provider of embedding and reranking models that power next-generation artificial intelligence applications.